TREOSULFAN, THIOTEPA AND FLUDARABINE CONDITIONING REGIMEN PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROMES: A SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Cassanello, Giulio [1 ]
Bagnoli, Filippo [2 ]
Saporiti, Giorgia [2 ]
Goldaniga, Maria [2 ]
Serpenti, Fabio [1 ]
Cavallaro, Francesca [2 ]
Barbullushi, Kordelia [2 ]
Galassi, Giulia [2 ]
Barcellini, Wilma [2 ]
Onida, Francesco [1 ,2 ]
机构：
[1] Univ Milan, Milan, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P164
引用
收藏
页码：264 / 265
页数：2
相关论文
共 50 条
  • [21] Conditioning with Treosulfan and Fludarabine followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
    Nemecek, Eneida R.
    Guthrie, Katherine A.
    Sorror, Mohamed L.
    Wood, Brent L.
    Doney, Kristine C.
    Hilger, Ralf A.
    Scott, Bart L.
    Kovacsovics, Tibor J.
    Maziarz, Richard T.
    Woolfrey, Ann E.
    Bedalov, Antonio
    Sanders, Jean E.
    Pagel, John M.
    Sickle, Eileen J.
    Witherspoon, Robert
    Flowers, Mary E.
    Appelbaum, Frederick R.
    Deeg, H. Joachim
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (03) : 341 - 350
  • [22] Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience
    Memoli, Mara
    Paviglianiti, Annalisa
    Malard, Florent
    Battipaglia, Giorgia
    Brissot, Eolia
    Mediavilla, Clemence
    Bianchessi, Antonio
    Banet, Anne
    Van de Wyngaert, Zoe
    Ledraa, Tounes
    Belhocine, Ramdane
    Sestili, Simona
    Lapusan, Simona
    Hirsch, Pierre
    Favale, Fabrizia
    Boussaroque, Agathe
    Bonnin, Agnes
    Vekhoff, Anne
    Legrand, Ollivier
    Mohty, Mohamad
    Dulery, Remy
    LEUKEMIA & LYMPHOMA, 2021, 62 (02) : 419 - 427
  • [23] Clofarabine and Total Body Irradiation as a Conditioning Regimen for Allogeneic Stem Cell Transplantation in High-Risk Acute Leukemia
    Atoui, Ali
    Dulery, Remy
    Terro, Khodr
    Abou Dalle, Iman
    Bazarbachi, Ali
    Mohty, Mohamad
    El Cheikh, Jean
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S432 - S432
  • [24] Intensified conditioning regimen with fludarabine combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in children with high-risk acute leukemia
    Cao, Junjie
    Xu, Xiaodong
    Lu, Ying
    Wang, Tiantian
    Chen, Dong
    Li, Shuangyue
    Liu, Xuhui
    Ye, Peipei
    Zheng, Zhong-zheng
    Pei, Renzhi
    HEMATOLOGY, 2023, 28 (01)
  • [25] Treosulfan in combination with fludarabine as part of conditioning treatment prior to allogeneic hematopoietic stem cell transplantation
    Ussowicz, M.
    DRUGS OF TODAY, 2020, 56 (06) : 389 - 403
  • [26] Sequential Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Zavrelova, Alzbeta
    Radocha, Jakub
    Lanska, Miriam
    Zak, Pavel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S312 - S312
  • [27] Preconditioning intervention prior to allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia
    Tachibana, Takayoshi
    Izumi, Akihiko
    Arai, Shota
    Takeda, Takaaki
    Hirose, Natsuki
    Tamai, Yotaro
    Sato, Shuku
    Hashimoto, Chizuko
    Fujimaki, Katsumichi
    Ishii, Ryuji
    Sakai, Hirotaka
    Yamazaki, Etsuko
    Inoue, Yasuyuki
    Tanaka, Masatsugu
    Nakajima, Hideaki
    EXPERIMENTAL HEMATOLOGY, 2025, 144
  • [28] TREOSULFAN-BASED CONDITIONING REGIMEN IN PEDIATRIC ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE SERIES OF SINGLE CENTER EXPERIENCE
    Sasmaz, Ilgen
    Antmen, Ali
    Aygunes, Utku
    Karagun, Barbaros
    Turksoy, Duygu
    BONE MARROW TRANSPLANTATION, 2024, 59 : 282 - 282
  • [29] Comparison of three reduced intensity conditioning (RIC) regimens for allogeneic stem cell transplantation of adult patients with high-risk acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS)
    Eder, M.
    Dammann, E.
    Beutel, G.
    Stamer, K.
    Hambach, L.
    Schwarzer, A.
    Hamwi, I.
    Lueck, C.
    Ehrlich, S.
    Ritter, U.
    Schuenemann, C.
    Schultze-Florey, C.
    Thol, F.
    Heuser, M.
    Koenecke, C.
    Stadler, M.
    Ganser, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S241 - S242
  • [30] UMBILICAL CORD BLOOD TRANSPLANTATION WITH REDUCED INTENSITY CONDITIONING IN ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME: A RETROSPECTIVE, SINGLE CENTER EXPERIENCE
    Torres, Nancy
    Kaabneh, Basil
    Aljitawi, Omar
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 626 - 626
12345